The First Foresight Training Course was held in Pavia, in September 2008 and was focused on the MA Centralised European Procedures and the Paediatric Regulation.
The Second Foresight Training Course, in line with other Gianni Benzi Foundation's initiatives promoting pharmacological research and innovation, was held in Pavia too in 2009 and dealt with the most innovative regulatory issues developed during the last years, particularly in the area of Advanced Therapies, Orphan Drugs and Paediatric Medicines.
The new centralised procedure for the registration of Advanced Therapy Medicinal Products (ATMPs) was analysed during the course, as well as the entire procedural process that leads to the registration of an Orphan Drug (OD). A special session was dedicated to innovation in the paediatric medicines field introduced by the recently approved European Paediatric Regulation.
The Second Foresight Training Course was organised in collaboration with the Master of Regulatory Science 'Gianni Benzi' held at Pavia's University and with TEDDY, the Task Force in Europe for Drug Development in the Young, a FP6 funded project aimed to the development of good quality medicines studied and tailored for children, SIAR (Italian Society for Regulatory Affairs) and MEGRA (Mittel Europäische Gesellschaft für Regulatory Affairs).
Key representatives from EMA, from the Italian Medicines Agency (AIFA) and from other National Agencies, together with other experienced speakers from academy, public bodies and pharmaceutical industries participated and contributed to the Course.
